Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Switzerland's Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials - EU-Startups
Nouscom is a biotechnology company developing novel cancer immunotherapies. Their innovative approach aims to bring advanced treatments closer to clinical trials. This funding will support the advancement of their pipeline.
Switzerland's Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials EU-Startups
You just read who funded Nouscom. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.